Mark Elliot is a Senior Vice President at ASG. He draws on a long career in business, government, and with industry associations to provide clients with strategic advice and analysis, with particular expertise in corporate affairs, intellectual property, health and life science, technology, and the political and regulatory environment in Australia. Mr. Elliot works closely with ASG’s Health practice.
As Executive Vice President of the Global Innovation Policy Center at the U.S. Chamber of Commerce, Mr. Elliot led the Chamber’s efforts to promote innovation and protect intellectual property standards. Working with global companies from a variety of sectors and foreign and domestic governments, he built coalitions to support the Center’s goals.
Previously, Mr. Elliot held leadership roles in Pfizer’s New York City headquarters and at Pfizer Australia. As the company’s Senior Director for International Public Affairs, he coordinated 26 country public affairs teams and navigated multiple major challenges, including pricing reforms and the EU financial crisis. Before moving to New York, he was Head of Public Affairs & Policy at Pfizer Australia. His private sector experience also includes management and communications roles with IBM and Solution 6.
Earlier in his career, Mr. Elliot served for ten years in various capacities with the Australian and New South Wales governments, first with the Parliament of New South Wales and later with the Parliament of Australia.
Mr. Elliot received his Bachelor’s degree from the University of Wollongong, and studied Business Strategy at the Macquarie Graduate School of Management.
He is based in Washington, DC.